DatabaseSearch date
MEDLINE (Ovid) and MEDLINE In-Process & Other Non-Indexed Citations: 1950 to present16 November 2009
EMBASE (Ovid): 1980 to 2009 week 46
PsycINFO (Ovid): 2002 to November week 2 2009
CCTR: 2009 Issue 413 November 2009
CDSR: 2009 Issue 4
CRD databases: NHS EED, HTA, DARE16 November 2009
ISI Web of Science: SCI
ISI Web of Science: CPCI
BIOSIS – via ISI Web of Science

CCTR, Cochrane controlled trials reports; CDSR, Cochrane Database of Systematic Reviews; CPCI, Conference Proceedings Citation Index; DARE, Database of Abstracts of Reviews of Effects; HTA, Health Technology Assessment database; SCI, Science Citation Index.

From: Appendix 2, Literature search strategies

Cover of The Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer's Disease (Review of Technology Appraisal No. 111): A Systematic Review and Economic Model
The Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer's Disease (Review of Technology Appraisal No. 111): A Systematic Review and Economic Model.
Health Technology Assessment, No. 16.21.
Bond M, Rogers G, Peters J, et al.
Southampton (UK): NIHR Journals Library; 2012 Apr.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.